Core Scientific (CORZ) Total Current Liabilities (2020 - 2026)

Core Scientific has disclosed Total Current Liabilities across 7 years of filings, most recently posting $2.7 billion for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $2.7 billion, up 1261.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 billion (up 1261.46% YoY), and the FY2025 annual result was $781.4 million, up 480.7% from the prior year.
• Total Current Liabilities came in at $2.7 billion for Q1 2026 at Core Scientific, up from $781.4 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.7 billion in Q1 2026 to a low of $74.8 million in Q2 2024.
• The 5-year median for Total Current Liabilities is $312.7 million (2023), against an average of $523.2 million.
• Across the five-year window, Total Current Liabilities jumped 50006.93% in 2022 and sank 75.74% in 2023, its largest moves.
• Core Scientific's Total Current Liabilities stood at $186.8 million in 2022, then surged by 161.48% to $488.4 million in 2023, then slumped by 72.45% to $134.6 million in 2024, then soared by 480.7% to $781.4 million in 2025, then soared by 240.64% to $2.7 billion in 2026.
• The last three Total Current Liabilities figures came in at $2.7 billion (Q1 2026), $781.4 million (Q4 2025), and $669.9 million (Q3 2025), per Business Quant data.